{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:35:54Z","timestamp":1791142554430,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1878,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.ccr.2008.05.004","type":"journal-article","created":{"date-parts":[[2008,7,8]],"date-time":"2008-07-08T10:45:53Z","timestamp":1215513953000},"page":"59-67","source":"Crossref","is-referenced-by-count":56,"title":["Loss of p21 Permits Carcinogenesis from Chronically Damaged Liver and Kidney Epithelial Cells despite Unchecked Apoptosis"],"prefix":"10.1016","volume":"14","author":[{"given":"Holger","family":"Willenbring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar Deep","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rothfuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton","family":"Finegold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Grompe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccr.2008.05.004_bib1","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1038\/sj.onc.1201728","article-title":"Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver","volume":"16","author":"Albrecht","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.ccr.2008.05.004_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/mgme.2001.3266","article-title":"Long-term therapy with NTBC and tyrosine-restricted diet in a murine model of hereditary tyrosinemia type I","volume":"75","author":"Al-Dhalimy","year":"2002","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ccr.2008.05.004_bib3","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0022-3565(24)29613-0","article-title":"Unique gene expression patterns in liver and kidney associated with exposure to chemical toxicants","volume":"297","author":"Bartosiewicz","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ccr.2008.05.004_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0092-8674(02)00716-X","article-title":"PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2","volume":"109","author":"Bhunia","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2008.05.004_bib5","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/377552a0","article-title":"Radiation-induced cell cycle arrest compromised by p21 deficiency","volume":"377","author":"Brugarolas","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2008.05.004_bib6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1535-6108(04)00058-3","article-title":"Focus on hepatocellular carcinoma","volume":"5","author":"Bruix","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2008.05.004_bib7","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1053\/j.gastro.2004.02.014","article-title":"Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice","volume":"126","author":"Calvisi","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ccr.2008.05.004_bib8","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00000478-198210000-00007","article-title":"Prognostic significance of morphologic parameters in renal cell carcinoma","volume":"6","author":"Fuhrman","year":"1982","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ccr.2008.05.004_bib9","first-page":"639","article-title":"The role of the cyclin-dependent kinase inhibitor p21 in apoptosis","volume":"1","author":"Gartel","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ccr.2008.05.004_bib10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1126\/science.286.5439.531","article-title":"Molecular classification of cancer: class discovery and class prediction by gene expression monitoring","volume":"286","author":"Golub","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ccr.2008.05.004_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/08941930390194424","article-title":"Partial hepatectomy in the mouse: technique and perioperative management","volume":"16","author":"Greene","year":"2003","journal-title":"J. Invest. Surg."},{"key":"10.1016\/j.ccr.2008.05.004_bib12","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1101\/gad.7.12a.2298","article-title":"Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice","volume":"7","author":"Grompe","year":"1993","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccr.2008.05.004_bib13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ng0895-453","article-title":"Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I","volume":"10","author":"Grompe","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccr.2008.05.004_bib14","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1097\/00007890-200206150-00020","article-title":"Liver repopulation after cell transplantation in mice treated with retrorsine and carbon tetrachloride","volume":"73","author":"Guo","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.ccr.2008.05.004_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/mutage\/18.1.45","article-title":"Recommendations for conducting the in vivo alkaline Comet assay. 4th International Comet Assay Workshop","volume":"18","author":"Hartmann","year":"2003","journal-title":"Mutagenesis"},{"key":"10.1016\/j.ccr.2008.05.004_bib16","series-title":"Pathology and Genetics of Tumours of the Digestive System","first-page":"159","article-title":"Hepatocellular carcinoma","author":"Hirohashi","year":"2000"},{"key":"10.1016\/j.ccr.2008.05.004_bib17","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1089-3261(05)70142-2","article-title":"Nontransplant treatment of tyrosinemia","volume":"4","author":"Holme","year":"2000","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.ccr.2008.05.004_bib18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/bbrc.1997.6220","article-title":"The mutagenicity of the tyrosine metabolite, fumarylacetoacetate, is enhanced by glutathione depletion","volume":"232","author":"Jorquera","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ccr.2008.05.004_bib19","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1093\/hmg\/10.17.1741","article-title":"Fumarylacetoacetate, the metabolite accumulating in hereditary tyrosinemia, activates the ERK pathway and induces mitotic abnormalities and genomic instability","volume":"10","author":"Jorquera","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ccr.2008.05.004_bib20","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1478-3231.2007.01499.x","article-title":"P21\/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection","volume":"27","author":"Kao","year":"2007","journal-title":"Liver Int."},{"key":"10.1016\/j.ccr.2008.05.004_bib21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/ng1097-179","article-title":"Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation","volume":"17","author":"Lu","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccr.2008.05.004_bib22","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0168-8278(03)00433-1","article-title":"Extensive changes in liver gene expression induced by hereditary tyrosinemia type I are not normalized by treatment with 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC)","volume":"39","author":"Luijerink","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ccr.2008.05.004_bib23","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1523-1755.2004.00788.x","article-title":"Renal proximal tubular cells acquire resistance to cell death stimuli in mice with hereditary tyrosinemia type 1","volume":"66","author":"Luijerink","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.ccr.2008.05.004_bib24","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/hep.20709","article-title":"An inhibitor of cyclin-dependent kinase, stress-induced p21Waf-1\/Cip-1, mediates hepatocyte mito-inhibition during the evolution of cirrhosis","volume":"41","author":"Lunz","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.ccr.2008.05.004_bib25","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/nbt762","article-title":"Conditional cell ablation by tight control of caspase-3 dimerization in transgenic mice","volume":"20","author":"Mallet","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccr.2008.05.004_bib26","first-page":"6234","article-title":"Tumor susceptibility of p21(Waf1\/Cip1)-deficient mice","volume":"61","author":"Martin-Caballero","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2008.05.004_bib27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1126\/science.276.5309.60","article-title":"Liver regeneration","volume":"276","author":"Michalopoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ccr.2008.05.004_bib28","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1074\/jbc.M412372200","article-title":"Heparin-binding epidermal growth factor-like growth factor links hepatocyte priming with cell cycle progression during liver regeneration","volume":"280","author":"Mitchell","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ccr.2008.05.004_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1749-6632.2002.tb04090.x","article-title":"Epidemiology, risk factors, and natural history of hepatocellular carcinoma","volume":"963","author":"Montalto","year":"2002","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1016\/j.ccr.2008.05.004_bib30","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/ng0396-266","article-title":"Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I","volume":"12","author":"Overturf","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccr.2008.05.004_bib31","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/hep.21552","article-title":"Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis","volume":"45","author":"Plentz","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.ccr.2008.05.004_bib32","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/j.gastro.2007.05.012","article-title":"Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction","volume":"133","author":"Richardson","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ccr.2008.05.004_bib33","first-page":"317","article-title":"Visceral pathology of hereditary tyrosinemia type I","volume":"47","author":"Russo","year":"1990","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ccr.2008.05.004_bib34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1054\/bjoc.2000.1310","article-title":"Reduced p21(WAF1\/CIP1) protein expression is predominantly related to altered p53 in hepatocellular carcinomas","volume":"83","author":"Shi","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ccr.2008.05.004_bib35","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0014-4827(88)90265-0","article-title":"A simple technique for quantitation of low levels of DNA damage in individual cells","volume":"175","author":"Singh","year":"1988","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ccr.2008.05.004_bib36","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00005176-200501000-00017","article-title":"Hepatocellular carcinoma in hereditary tyrosinemia type I despite 2-(2 nitro-4-3 trifluoro- methylbenzoyl)-1, 3-cyclohexanedione treatment","volume":"40","author":"van Spronsen","year":"2005","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.ccr.2008.05.004_bib37","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/hep.20077","article-title":"Chronic liver disease in murine hereditary tyrosinemia type 1 induces resistance to cell death","volume":"39","author":"Vogel","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.ccr.2008.05.004_bib38","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1023\/A:1011977923941","article-title":"p21WAF1\/CTP1 expression and hepatitis virus type","volume":"46","author":"Wagayama","year":"2001","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ccr.2008.05.004_bib39","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1535-6108(03)00308-8","article-title":"p21Waf1\/Cip1 as a therapeutic target in breast and other cancers","volume":"4","author":"Weiss","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2008.05.004_bib40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1101\/gad.10.3.245","article-title":"Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration","volume":"10","author":"Wu","year":"1996","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccr.2008.05.004_bib41","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/nrm1443","article-title":"Apoptosis and genomic instability","volume":"5","author":"Zhivotovsky","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ccr.2008.05.004_bib42","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/35060032","article-title":"Cytoplasmic localization of p21Cip1\/WAF1 by Akt-induced phosphorylation in HER-2\/neu-overexpressing cells","volume":"3","author":"Zhou","year":"2001","journal-title":"Nat. Cell Biol."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610808001591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610808001591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T23:42:07Z","timestamp":1738280527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610808001591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S1535610808001591"],"URL":"https:\/\/doi.org\/10.1016\/j.ccr.2008.05.004","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}